- Article metrics
- Last updated: Mon, 23 Feb 2026 16:12:55 Z
A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors
Access & Citations
-
- 2784
- Article Accesses
-
- Not available
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.